BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20482627)

  • 1. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice.
    Zhang T; Kurita-Ochiai T; Hashizume T; Du Y; Oguchi S; Yamamoto M
    FEMS Immunol Med Microbiol; 2010 Jul; 59(2):143-51. PubMed ID: 20482627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice.
    Tuomainen AM; Jauhiainen M; Kovanen PT; Metso J; Paju S; Pussinen PJ
    Microb Pathog; 2008 Feb; 44(2):111-7. PubMed ID: 17889499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal pathogen accelerates lipid peroxidation and atherosclerosis.
    Jia R; Kurita-Ochiai T; Oguchi S; Yamamoto M
    J Dent Res; 2013 Mar; 92(3):247-52. PubMed ID: 23355524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregatibacter actinomycetemcomitans induces Th17 cells in atherosclerotic lesions.
    Jia R; Hashizume-Takizawa T; Du Y; Yamamoto M; Kurita-Ochiai T
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25743474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice.
    Tuomainen AM; Hyvärinen K; Ehlers PI; Mervaala E; Leinonen M; Saikku P; Kovanen PT; Jauhiainen M; Pussinen PJ
    Microb Pathog; 2011 Sep; 51(3):217-24. PubMed ID: 21421042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual vaccine with GroEL attenuates atherosclerosis.
    Hagiwara M; Kurita-Ochiai T; Kobayashi R; Hashizume-Takizawa T; Yamazaki K; Yamamoto M
    J Dent Res; 2014 Apr; 93(4):382-7. PubMed ID: 24554540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells.
    Oksaharju A; Lappalainen J; Tuomainen AM; Pussinen PJ; Puolakkainen M; Kovanen PT; Lindstedt KA
    J Cell Mol Med; 2009 Jan; 13(1):103-13. PubMed ID: 18298659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
    George J; Afek A; Abashidze A; Shmilovich H; Deutsch V; Kopolovich J; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2636-41. PubMed ID: 16195475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
    Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
    Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
    Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
    Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
    Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
    Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
    Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.